Single Nucleotide Polymorphisms Genotyping Market Size, Share & Trends Analysis Report By Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays), By Application (Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceu

Single Nucleotide Polymorphisms Genotyping Market Analysis and Insights

The Single Nucleotide Polymorphisms Genotyping Market size is anticipated to reach USD 9.6 billion in 2023 and it is projected to reach USD 22.6 billion by 2032, growing at a CAGR of 10% during the forecast period.

The Global Single Nucleotide Polymorphisms Genotyping Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Single Nucleotide Polymorphisms Genotyping Market growth, Size report provides a comprehensive analysis of the Biotechnology industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Single Nucleotide Polymorphisms Genotyping Market includes major supplies & Independent Consultants among others.

Global Market Scope and Single Nucleotide Polymorphisms Genotyping Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Single Nucleotide Polymorphisms Genotyping Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Single Nucleotide Polymorphisms Genotyping Market Country Level Analysis

The Global Single Nucleotide Polymorphisms Genotyping Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Single Nucleotide Polymorphisms Genotyping Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Single Nucleotide Polymorphisms Genotyping Market

Some of the other major highlights of the demand for Single Nucleotide Polymorphisms Genotyping Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Single Nucleotide Polymorphisms Genotyping Market during the forecast period.

  • Agilent Technologies Inc.
  • Eurofins Genomics (Eurofins Scientific SE)
  • Illumina Inc.
  • Integrated DNA Technologies, Inc. (Danaher Corporation)
  • LGC Limited
  • PREMIER Biosoft
  • Promega Corporation
  • QIAGEN N.V
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.

Market Segmentation

The Global Single Nucleotide Polymorphisms Genotyping Market Share, Demand provides the most up-to-date Biotechnology industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.
  • By Technology
    • TaqMan SNP Genotyping
    • Massarray SNP Genotyping
    • SNP GeneChip Arrays
  • By Application
    • Animal Genetics
    • Plant Improvement
    • Diagnostic Research
    • Pharmaceuticals and Pharmacogenomics
    • Agricultural Biotechnology

Regions Coverd
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Nordic
    • Benelux
    • Rest of Europe
  • APAC
    • China
    • Korea
    • Japan
    • India
    • Australia
    • Singapore
    • Taiwan
    • South East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • UAE
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt
    • Nigeria
    • Rest of MEA
  • LATAM
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest of LATAM

Reasons for Doing the Study:

This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.


1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Single Nucleotide Polymorphisms Genotyping Market Size Analysis
6.1 By Technology
6.1.1 TaqMan SNP Genotyping
6.1.2 Massarray SNP Genotyping
6.1.3 SNP GeneChip Arrays
6.2 By Application
6.2.1 Animal Genetics
6.2.2 Plant Improvement
6.2.3 Diagnostic Research
6.2.4 Pharmaceuticals and Pharmacogenomics
6.2.5 Agricultural Biotechnology
7 North America Market Analysis
7.1 By Technology
7.1.1 TaqMan SNP Genotyping
7.1.2 Massarray SNP Genotyping
7.1.3 SNP GeneChip Arrays
7.2 By Application
7.2.1 Animal Genetics
7.2.2 Plant Improvement
7.2.3 Diagnostic Research
7.2.4 Pharmaceuticals and Pharmacogenomics
7.2.5 Agricultural Biotechnology
7.2 U.S.
7.3 Canada
8 Europe Market Analysis
8.1 By Technology
8.1.1 TaqMan SNP Genotyping
8.1.2 Massarray SNP Genotyping
8.1.3 SNP GeneChip Arrays
8.2 By Application
8.2.1 Animal Genetics
8.2.2 Plant Improvement
8.2.3 Diagnostic Research
8.2.4 Pharmaceuticals and Pharmacogenomics
8.2.5 Agricultural Biotechnology
8.2 U.K.
8.3 Germany
8.4 France
8.5 Spain
8.6 Italy
8.7 Russia
8.8 Nordic
8.9 Benelux
8.10 Rest of Europe
9 APAC Market Analysis
9.1 By Technology
9.1.1 TaqMan SNP Genotyping
9.1.2 Massarray SNP Genotyping
9.1.3 SNP GeneChip Arrays
9.2 By Application
9.2.1 Animal Genetics
9.2.2 Plant Improvement
9.2.3 Diagnostic Research
9.2.4 Pharmaceuticals and Pharmacogenomics
9.2.5 Agricultural Biotechnology
9.2 China
9.3 Korea
9.4 Japan
9.5 India
9.6 Australia
9.7 Singapore
9.8 Taiwan
9.9 South East Asia
9.10 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Technology
10.1.1 TaqMan SNP Genotyping
10.1.2 Massarray SNP Genotyping
10.1.3 SNP GeneChip Arrays
10.2 By Application
10.2.1 Animal Genetics
10.2.2 Plant Improvement
10.2.3 Diagnostic Research
10.2.4 Pharmaceuticals and Pharmacogenomics
10.2.5 Agricultural Biotechnology
10.2 UAE
10.3 Turkey
10.4 Saudi Arabia
10.5 South Africa
10.6 Egypt
10.7 Nigeria
10.8 Rest of MEA
11 LATAM Market Analysis
11.1 By Technology
11.1.1 TaqMan SNP Genotyping
11.1.2 Massarray SNP Genotyping
11.1.3 SNP GeneChip Arrays
11.2 By Application
11.2.1 Animal Genetics
11.2.2 Plant Improvement
11.2.3 Diagnostic Research
11.2.4 Pharmaceuticals and Pharmacogenomics
11.2.5 Agricultural Biotechnology
11.2 Brazil
11.3 Mexico
11.4 Argentina
11.5 Chile
11.6 Colombia
11.7 Rest of LATAM
12 Competitive Landscape
12.1 Global Single Nucleotide Polymorphisms Genotyping Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.1 American International Industries (GIGI)
13.1.1 Overview
13.1.2 Business Information
13.1.3 Revenue
13.1.4 ASP
13.1.5 Swot Analysis
13.1.6 Recent Developments
13.2 Eurofins Genomics (Eurofins Scientific SE)
13.3 Illumina Inc.
13.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
13.5 LGC Limited
13.6 PREMIER Biosoft
13.7 Promega Corporation
13.8 QIAGEN N.V
13.9 Roche Holding AG
13.10 Thermo Fisher Scientific Inc.
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings